First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children
Research output: Contribution to journal › Journal article › Research › peer-review
An ongoing phase 3 study of the efficacy, safety, and immunogenicity of candidate malaria vaccine RTS,S/AS01 is being conducted in seven African countries.
Original language | English |
---|---|
Journal | New England Journal of Medicine |
Volume | 365 |
Issue number | 20 |
Pages (from-to) | 1863-75 |
Number of pages | 13 |
ISSN | 0028-4793 |
DOIs | |
Publication status | Published - 2011 |
- Africa, Age Factors, Double-Blind Method, Female, Follow-Up Studies, Humans, Incidence, Infant, Intention to Treat Analysis, Malaria Vaccines, Malaria, Falciparum, Male, Meningitis, Parasite Load, Plasmodium falciparum, Seizures, Treatment Outcome
Research areas
ID: 35917734